Current and historical daily PE Ratio for Kontafarma China Holdings Ltd (
HKSE:01312
) from 2012 to Jun 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kontafarma China stock (HKSE:01312) PE ratio as of Jun 15 2024 is 0.
More Details
Kontafarma China Holdings Ltd (HKSE:01312) PE Ratio (TTM) Chart
Kontafarma China Holdings Ltd (HKSE:01312) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Kontafarma China PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-15 | At Loss | 2024-04-10 | At Loss |
2024-06-14 | At Loss | 2024-04-09 | At Loss |
2024-06-13 | At Loss | 2024-04-08 | At Loss |
2024-06-12 | At Loss | 2024-04-05 | At Loss |
2024-06-11 | At Loss | 2024-04-03 | At Loss |
2024-06-07 | At Loss | 2024-04-02 | At Loss |
2024-06-06 | At Loss | 2024-03-28 | At Loss |
2024-06-05 | At Loss | 2024-03-27 | At Loss |
2024-06-04 | At Loss | 2024-03-26 | At Loss |
2024-06-03 | At Loss | 2024-03-25 | At Loss |
2024-05-31 | At Loss | 2024-03-22 | At Loss |
2024-05-30 | At Loss | 2024-03-21 | At Loss |
2024-05-29 | At Loss | 2024-03-20 | At Loss |
2024-05-28 | At Loss | 2024-03-19 | At Loss |
2024-05-27 | At Loss | 2024-03-18 | At Loss |
2024-05-24 | At Loss | 2024-03-15 | At Loss |
2024-05-23 | At Loss | 2024-03-14 | At Loss |
2024-05-22 | At Loss | 2024-03-13 | At Loss |
2024-05-21 | At Loss | 2024-03-12 | At Loss |
2024-05-20 | At Loss | 2024-03-11 | At Loss |
2024-05-17 | At Loss | 2024-03-08 | At Loss |
2024-05-16 | At Loss | 2024-03-07 | At Loss |
2024-05-14 | At Loss | 2024-03-06 | At Loss |
2024-05-13 | At Loss | 2024-03-05 | At Loss |
2024-05-10 | At Loss | 2024-03-04 | At Loss |
2024-05-09 | At Loss | 2024-03-01 | At Loss |
2024-05-08 | At Loss | 2024-02-29 | At Loss |
2024-05-07 | At Loss | 2024-02-28 | At Loss |
2024-05-06 | At Loss | 2024-02-27 | At Loss |
2024-05-03 | At Loss | 2024-02-26 | At Loss |
2024-05-02 | At Loss | 2024-02-23 | At Loss |
2024-04-30 | At Loss | 2024-02-22 | At Loss |
2024-04-29 | At Loss | 2024-02-21 | At Loss |
2024-04-26 | At Loss | 2024-02-20 | At Loss |
2024-04-25 | At Loss | 2024-02-19 | At Loss |
2024-04-24 | At Loss | 2024-02-16 | At Loss |
2024-04-23 | At Loss | 2024-02-15 | At Loss |
2024-04-22 | At Loss | 2024-02-14 | At Loss |
2024-04-19 | At Loss | 2024-02-09 | At Loss |
2024-04-18 | At Loss | 2024-02-08 | At Loss |
2024-04-17 | At Loss | 2024-02-07 | At Loss |
2024-04-16 | At Loss | 2024-02-06 | At Loss |
2024-04-15 | At Loss | 2024-02-05 | At Loss |
2024-04-12 | At Loss | 2024-02-02 | At Loss |
2024-04-11 | At Loss | 2024-02-01 | At Loss |
Kontafarma China Holdings Ltd (HKSE:01312) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Kontafarma China Holdings Ltd
NAICS : 327310
ISIN : KYG8918D1088
Compare
Compare
Traded in other countries / regions
01312.Hong Kong IPO Date
2012-01-18Description
Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises. The operating segments include the pharmaceutical business and the Fitness business. The majority of its revenue derives from the pharmaceutical business segment.